Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03IDK
|
||||
Former ID |
DIB002091
|
||||
Drug Name |
CEP-18050
|
||||
Synonyms |
ALK inhibitors (anaplastic large cell lymphoma); CEP-18050; ALK inhibitors (anaplastic large cell lymphoma), Cephalon; Alk inhibitors (cancer), Cephalon
|
||||
Indication | Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] | Investigative | [543509] | ||
Company |
Cephalon Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1c(c(cc2c1CCN(CC2)CC(=O)N(C)C)OC)Nc1nc(c(cn1)Cl)Nc1c(c<br />c(cc1)N1CCOCC1)OC
|
||||
Target and Pathway | |||||
Target(s) | ALK tyrosine kinase receptor | Target Info | Inhibitor | [543509] | |
KEGG Pathway | Non-small cell lung cancer | ||||
WikiPathways | Differentiation Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.